MCS NYSE
The Marcus Corporation
1W: +5.3%
1M: -1.7%
3M: +12.3%
YTD: +20.8%
1Y: +9.4%
3Y: +21.2%
5Y: -2.5%
$18.08
-0.24 (-1.31%)
Weekly Expected Move ±5.8%
$15
$16
$17
$18
$19
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.90
Bullish
1 bullish
0 neutral
0 bearish
Articles (24h)
1
Hourly Sentiment (24h)
Articles (1)
0.90
Bullish
1 bullish
0 neutral
0 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (47)
Marcus declares $0.08 dividend
The Marcus Corporation Q1 2026 Earnings Call Summary
Marcus (MCS) Q1 2026 Earnings Call Transcript
Marcus Q1 2026 Earnings Call: Complete Transcript
Marcus (MCS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Marcus (MCS) Reports Q1 Loss, Beats Revenue Estimates
Marcus GAAP EPS of $0.51 beats by $1.07, revenue of $154.4M beats by $4.87M
Earnings Scheduled For April 30, 2026
AMC Entertainment (AMC) Expected to Beat Earnings Estimates: Should You Buy?
Don't Buy AMC Entertainment Until This Happens
Marcus (MCS) Expected to Beat Earnings Estimates: Should You Buy?
Disney debuts Infinity Vision to rival IMAX -- report
Box office buzz: Best quarter in five years fuels hopes for Hollywood comeback
American Century Companies Inc. Has $14.16 Million Holdings in Marcus Corporation (The) $MCS
Marcus Corporation outlines $50M–$55M capital spending plan for 2026 with focus on free cash flow and strategic investments
The Marcus Corporation (MCS) Q4 2025 Earnings Call Transcript
Marcus (MCS) Reports Q4 Earnings: What Key Metrics Have to Say
Marcus (MCS) Reports Q4 Loss, Tops Revenue Estimates
Marcus GAAP EPS of $0.19 beats by $0.05, revenue of $193.5M beats by $8.31M
Marcus Corporation Reports Fourth Quarter and Full Year Fiscal 2025 Results
Letter to Shareholders From Marcus Lemonis, Executive Chairman and CEO: 2025 Year End Letter and 2026 Outlook
Marcus & Millichap: High Forecasts, Fragile Backdrop
Antimony Resources Corp. (ATMY) (ATMYF) (K8J0) Continues to Expose New Massive Antimony-Bearing Stibnite Mineralization in the Marcus Zone
Marcus & Millichap, Inc. Reports Preliminary Results for Fourth Quarter and Full Year 2025
New Discovery of Massive Stibnite (Antimony) on Globex's Bald Hill Property
Jyong Biotech Reports Transformative Period of Clinical Validation and Commercialization Attempt: Phase II Data Focuses on Dual Therapeutic Potential of MCS-8 in Oncology and Metabolic Health, Alongside Strategic Market Entry into Asia
Marcus Corporation Announces Fourth Quarter and Full Year Fiscal 2025 Release Date and Conference Call
Marcus Corporation Declares Quarterly Dividend
Marcus & Millichap Declares Regular Semi-Annual Dividend of $0.25 Per Share
Antimony Resources Corp. (ATMY) (ATMYF) (K8J0) Discovers New Massive Stibnite Mineralization at the Marcus (West) Zone and Have Exposed the Mineralization in Bedrock over a Distance of 25 Meters
Jyong Biotech Subsidiary Announces Phase II Clinical Data on Cholesterol and LDH Indicators for MCS-8 (PCP), Indicating Potential in Prostate Cancer Prevention and Metabolic Value
Marcus Corporation (The) (NYSE:MCS) Receives $23.75 Average Price Target from Analysts
The Marc Hotel Officially Opens its Doors in Downtown Milwaukee
Marcus Theatres Adopts Pixelworks' TrueCut Motion Format to Deliver the Ultimate Premium Movie Experience
HYTN Announces Engagement of Marketing and Communications Services Provider
Marcus Lemonis named Bed Bath & Beyond CEO, details future plans for retailer
Bed Bath & Beyond names insider Marcus Lemonis as CEO
Letter to Shareholders and Stakeholders from Marcus Lemonis, Executive Chairman and Chief Executive Officer of Bed Bath & Beyond
Marcus Theatres Celebrates National Popcorn Day with Free Popcorn for Moviegoers Nationwide
Critical Survey: Marcus (NYSE:MCS) and AiRWA (NASDAQ:YYAI)
Blockbusters, Comedies and Family Favorites Dominate Pre-Christmas Weekend at Marcus Theatres
Hilton Milwaukee Completes $42 Million Transformation
Analyzing Studio City Ih (NYSE:MSC) and Marcus (NYSE:MCS)
Classic Holiday Favorites Return to the Big Screen at Marcus Theatres
Wicked: For Good Delivers Magical Weekend at Marcus Theatres
Jyong Biotech Ltd. Signs Non‑Binding Letter of Intent with Leading South Korean Pharmaceutical Company to Evaluate In‑Licensing of Plant-Derived MCS Drugs
Jyong Biotech Announces Completion of Primary Endpoint Statistical Analysis for Phase II Clinical Trial of MCS-8 With Positive Outcomes